Vis enkel innførsel

dc.contributor.authorBarca, Maria Lage
dc.contributor.authorPersson, Karin
dc.contributor.authorEldholm, Rannveig Sakshaug
dc.contributor.authorSaltyte Benth, Jurate
dc.contributor.authorKersten, Hege
dc.contributor.authorKnapskog, Anne-Brita
dc.contributor.authorSaltvedt, Ingvild
dc.contributor.authorSelbæk, Geir
dc.contributor.authorEngedal, Knut
dc.date.accessioned2018-01-19T12:57:55Z
dc.date.available2018-01-19T12:57:55Z
dc.date.created2017-07-18T10:30:38Z
dc.date.issued2017
dc.identifier.citationJournal of Affective Disorders. 2017, 222 146-152.nb_NO
dc.identifier.issn0165-0327
dc.identifier.urihttp://hdl.handle.net/11250/2478382
dc.description.abstractBackground The relationship between progression of Alzheimer's disease and depression and its underlying mechanisms has scarcely been studied. Methods A sample of 282 outpatients with Alzheimer's disease (AD; 105 with amnestic AD and 177 with Alzheimer's dementia) from Norway were followed up for an average of two years. Assessment included Cornell Scale for Depression in Dementia and Clinical Dementia Rating Scale (CDR) at baseline and follow-up to examine the relationship between AD and depression. Additionally, MRI of the brain, CSF dementia biomarkers and APOE status were assessed at baseline. Progression of dementia was defined as the difference between CDR sum of boxes at follow-up and baseline (CDR-SB change). Trajectories of depressive symptoms on the Cornell Scale were identified using growth mixture modeling. Differences between the trajectories in regard to patients’ characteristics were investigated. Results Three distinct trajectories of depressive symptoms were identified: 231 (82.8%) of the patients had stable low-average scores on the Cornell Scale (Class 1); 11 (3.9%) had high and decreasing scores (Class 2); and 37 (13.3%) had moderate and increasing scores (Class 3). All classes had average probabilities over 80%, and confidence intervals were non-overlapping. The only significant characteristic associated with membership in class 3 was CDR-SB change. Limitations Not all patients screened for participation were included in the study, but the included and non-included patients did not differ significantly. Some patients with amnestic MCI might have been misdiagnosed. Conclusion A more rapid progression of dementia was found in a group of patients with increasing depressive symptoms.nb_NO
dc.language.isoengnb_NO
dc.publisherElseviernb_NO
dc.relation.urihttp://www.sciencedirect.com/science/article/pii/S016503271730397X?via%3Dihub
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleTrajectories of depressive symptoms and their relationship to the progression of dementianb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionacceptedVersionnb_NO
dc.source.pagenumber146-152nb_NO
dc.source.volume222nb_NO
dc.source.journalJournal of Affective Disordersnb_NO
dc.identifier.doi10.1016/j.jad.2017.07.008
dc.identifier.cristin1482481
dc.description.localcode© 2017. This is the authors’ accepted and refereed manuscript to the article. Locked until 8.7.2019 due to copyright restrictions. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/nb_NO
cristin.unitcode194,65,30,0
cristin.unitnameInstitutt for nevromedisin og bevegelsesvitenskap
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal